Evaluation of a new Syphilis assay on Vitros® 5600 Integrated System


Submitted: 14 February 2014
Accepted: 14 February 2014
Published: 31 December 2010
Abstract Views: 1194
PDF: 1289
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Introduction. A new homogeneous immunoassay for detection of primary infection of Treponema Pallidum (TP) on Vitros® 5600 Integrated System was evaluated.The scope of the study was to verify analytical performances and diagnostic accuracy in comparison to commercial methods (Immunoblotting test, ELISA test, Immunoturbidimetric test). Methods. The new Syphilis assay from SENTINEL CH. SpA, is an immunoturbidimetric assay, using microparticles coated with TP fixed on the surface of polystyrene latex particles which agglutinate by an antigen-antibody reaction when anti-TP antigen is present in the specimen. The assay was implemented on Vitros® 5600 Integrated System. Modified CLSI protocols were adopted. Acceptance criteria for total imprecision were 5% for negative samples (or SD 0.5 U/mL) and 4% for positive samples. In comparison to commercial methods, sensitivity must be 99.5% and specificity 99.5%. Results. Total imprecision (22 days) gave SD at 6 U/mL lower than 0.5 U/mL, and CV% at 10 U/mL and 45 U/mL lower than 4%. Low quantitation limit is 5 U/mL. No prozone up to 13000 U/mL was found. In the on-board calibration stability study no drift was found up to 4 weeks. 153 samples were tested vs immunoblotting method and specificity was 100%, sensitivity was 100%. 495 samples were tested vs ELISA method and test specificity and sensitivity were 99.6% and 100% respectively. 521 samples were tested vs immunoturbidimetric method and specificity was 99.8%, sensitivity was 100%. Interference from Bilirubin (20 mg/dL), Hemoglobin (500 mg/dL) and Triglycerides (1000 mg/dL) was not detected.All the sample collection tubes tested (K2EDTA, SST, LH PST II, LH, NH) did not interfere with the assay. Conclusion. Performances of the new SENTINEL Syphilis assay on Vitros® 5600 Integrated System meet the requirements for its use as screening tool in blood bank, thus allowing consolidation with general chemistry on a single high volume chemistry analyzer, which is highly valuable for optimizing workflow and efficiency in today’s laboratories.

Longo, G., Bitella, C., La Motta, M., Lucini, R., Rota, F., Serra, A. G., & Vigo, E. (2010). Evaluation of a new Syphilis assay on Vitros® 5600 Integrated System. Microbiologia Medica, 25(4). https://doi.org/10.4081/mm.2010.2395

Downloads

Download data is not yet available.

Citations